Feb 29, 2016 8:55am EST Pieris Pharmaceuticals to Present at the 28th Annual ROTH Conference on March 15th at 10:30 am PDT
Jan 28, 2016 8:30am EST Pieris Pharmaceuticals to Present at the 18th Annual BIO CEO and Investor Conference on February 8th at 9:30 am ET
Dec 07, 2015 9:00am EST Pieris Pharmaceuticals Presents Clinical Data for Its Hepcidin Antagonist Program, PRS-080, at the 2015 American Society of Hematology (Ash) Annual Meeting
Dec 01, 2015 9:24am EST Pieris Pharmaceuticals to Present at the Oppenheimer 26th Annual Healthcare Conference on December 8th at 3:55 pm EST
Nov 24, 2015 8:00am EST Pieris Pharmaceuticals CEO to Present at the LD Micro Main Event on December 3rd
Nov 19, 2015 8:00am EST Pieris Pharmaceuticals Collaborator Daiichi Sankyo Doses First Subject in a Phase 1 Clinical Study for Lead Partnered Anticalin Program
Nov 11, 2015 5:45pm EST Pieris Pharmaceuticals Reports Financial Results for the Third Quarter Ended September 30, 2015
Nov 06, 2015 8:00am EST Pieris Pharmaceuticals Presents Data at SITC Conference on Lead Immuno-Oncology Program Demonstrating Selective Tumor-Targeted Immune Responses
